Markets We Serve

Therapeutic Characterization

Develop Safe & Effective Therapeutics

MOBILion helps pharmaceutical and biopharma R&D labs bring safe, effective therapeutics to market sooner. The MOBIE instrument separates post-translational modifications (PTMs) that make therapeutics unsafe or ineffective.

Released Glycan Analysis
Peptide Isomerization Analysis
Intact & Subunit Analysis
Post-Translational Modifications Analysis

‍

Featured Resources

MOBIE️® HRIM Platform D-Amino Acid Peptide Analysis

Application Notes

MOBIE️® HRIM Platform D-Amino Acid Peptide Analysis

High-resolution ion mobility (HRIM) enables rapid, robust characterization of challenging isomeric, unnatural peptide modifications in discovery and process development labs.

High-Throughput Monitoring of Biotherapeutic Critical Quality Attributes with MOBIE

Application Notes

High-Throughput Monitoring of Biotherapeutic Critical Quality Attributes with MOBIE

Add MOBIE into traditional LC-MS characterization workflows to perform rapid, targeted analysis of CQAs.

Applicable Workflows

Targeted Lipidomics

Identify more isomers, more quickly, in complex biological systems to further your disease research.

Glycan Analysis

Detect isomers that impact product characteristics, with unsurpassed accuracy and speed.

Lipid Nanoparticle Analysis

Improve identification accuracy from interferents and eliminate overlapping isotope profiles.

Schedule a Chat Today!

MOBILion Wave Hero

MOBILion is the exclusive licensee of the SLIM technology for commercialization purposes. For research use only. Not for diagnostic procedures. MOBIE, MOBILion and REVEALING WHAT OTHERS LEAVE UNSEEN are registered trademarks of MOBILion Systems, Inc.